Ohcanbohtosat - Eva Hubmann
- Čájehuvvo 1 - 2 / 2
-
1
Granulocyte Colony-Stimulating Factor as an Adjunct to Induction Chemotherapy for Adult Acute Lymphoblastic Leukemia — A Randomized Phase-III Study Dahkki Klaus Geißler, Elisabeth Koller, Eva Hubmann, Dietger Niederwieser, W Hinterberger, D. Geißler, Paul A. Kyrle, Paul Knöbl, Ingrid Pabinger, Renate Thalhammer, Ilse Schwarzinger, Christine Mannhalter, Ulrich Jaeger, R. Heinz, Werner Linkesch, Klaus Lechner
Almmustuhtton 1997Artigo -
2
The AST/ALT (De Ritis) ratio predicts clinical outcome in patients with pancreatic cancer treated with first-line nab-paclitaxel and gemcitabine: <i>post hoc</i> analysis of an Aus... Dahkki Jakob M. Riedl, Florian Posch, Gerald W. Prager, Wolfgang Eisterer, Leopold Oehler, Thamer Sliwa, Klaus Wilthoner, Andreas Petzer, Petra Pichler, Eva Hubmann, Thomas Winder, Sonja Burgstaller, Markus Korger, Johannes Andel, Richard Greil, H Neumann, Martin Pecherstorfer, Kathrin Philipp‐Abbrederis, Angela Djanani, Birgit Gruenberger, Friedrich Laengle, Ewald Wöll, Armin Gerger
Almmustuhtton 2020Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Gastroenterology
Internal medicine
Medicine
Absolute neutrophil count
Cancer
Chemotherapy
Concomitant
Confidence interval
Cyclophosphamide
Daunorubicin
Febrile neutropenia
Filgrastim
Gemcitabine
Granulocyte colony-stimulating factor
Hazard ratio
Neutropenia
Oncology
Pancreatic cancer
Post-hoc analysis
Proportional hazards model
Surgery
Vincristine